Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Neuprez

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|November 30, 2014
Efficacy and safety of currently marketed anti-osteoporosis medicationsJ Y Reginster, A Neuprez, N Dardenne, et al.
Journal of Medical Economics|November 11, 2009
Impact of chondroitin sulphate on health utility in patients with knee osteoarthritis: towards economic analysisO Bruyère, S Scholtissen, A Neuprez, et al.
Revue Medicale De Liege|August 28, 2014
[Treatment of post-menopausic osteoporosis: what's new in 2014?]J-Y Reginster, A Neuprez, M P Lecart, et al.
Panminerva Medica|March 20, 2014
Bone forming agents for the management of osteoporosisJ Y Reginster, A Neuprez, Ch Beaudart, et al.
Rheumatology International|July 31, 2012
Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security and the new suggested FRAX criteriaO Bruyère, M Fossi, B Zegels, et al.
Revue Medicale De Liege|August 20, 2015
[OSTEOPOROSIS AND PERSONALIZED MEDICINE]J Y Reginster, A Neuprez, M P Lecart, et al.
Archives of Orthopaedic and Trauma Surgery|July 31, 2012
Health-related quality of life after total knee or hip replacement for osteoarthritis: a 7-year prospective studyO Bruyère, O Ethgen, A Neuprez, et al.
Drugs & Aging|May 7, 2014
Antiresorptive drugs beyond bisphosphonates and selective oestrogen receptor modulators for the management of postmenopausal osteoporosisJ Y Reginster, A Neuprez, C Beaudart, et al.
International Journal of Clinical Practice|June 4, 2010
Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamolS Scholtissen, O Bruyère, A Neuprez, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 31, 2010
A FRAX® model for the assessment of fracture probability in BelgiumH Johansson, J A Kanis, E V McCloskey, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Best Practice & Research. Clinical Endocrinology & Metabolism|November 30, 2014
Efficacy and safety of currently marketed anti-osteoporosis medicationsJ Y Reginster, A Neuprez, N Dardenne, et al.
Journal of Medical Economics|November 11, 2009
Impact of chondroitin sulphate on health utility in patients with knee osteoarthritis: towards economic analysisO Bruyère, S Scholtissen, A Neuprez, et al.
Revue Medicale De Liege|August 28, 2014
[Treatment of post-menopausic osteoporosis: what's new in 2014?]J-Y Reginster, A Neuprez, M P Lecart, et al.
Panminerva Medica|March 20, 2014
Bone forming agents for the management of osteoporosisJ Y Reginster, A Neuprez, Ch Beaudart, et al.
Rheumatology International|July 31, 2012
Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security and the new suggested FRAX criteriaO Bruyère, M Fossi, B Zegels, et al.
Revue Medicale De Liege|August 20, 2015
[OSTEOPOROSIS AND PERSONALIZED MEDICINE]J Y Reginster, A Neuprez, M P Lecart, et al.
Archives of Orthopaedic and Trauma Surgery|July 31, 2012
Health-related quality of life after total knee or hip replacement for osteoarthritis: a 7-year prospective studyO Bruyère, O Ethgen, A Neuprez, et al.
Drugs & Aging|May 7, 2014
Antiresorptive drugs beyond bisphosphonates and selective oestrogen receptor modulators for the management of postmenopausal osteoporosisJ Y Reginster, A Neuprez, C Beaudart, et al.
International Journal of Clinical Practice|June 4, 2010
Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamolS Scholtissen, O Bruyère, A Neuprez, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 31, 2010
A FRAX® model for the assessment of fracture probability in BelgiumH Johansson, J A Kanis, E V McCloskey, et al.
Pageof 3